K964270 · Universal Reagents, Inc. · GGP · Dec 18, 1996 · Hematology
Device Facts
Record ID
K964270
Device Name
UNIVERSAL REAGENT FACTOR V DEFICIENT PLASMA
Applicant
Universal Reagents, Inc.
Product Code
GGP · Hematology
Decision Date
Dec 18, 1996
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 864.7290
Device Class
Class 2
Intended Use
Indicated use - Factor deficient plasma, Factor - V is a human plasma immunodepleted of the specific factor and intended for use in the quantitative determination of the specific factor levels in patients suspected of congenital or acquired deficiency of this specific coagulation protein and is performed by clotting assay.
Device Story
Factor deficient coagulation plasma - V is human plasma immunodepleted of Factor V antigen. Used in clinical laboratories by technicians to perform quantitative clotting assays. Device serves as reagent to determine Factor V levels in patient plasma samples. Provides diagnostic information for congenital or acquired coagulation protein deficiencies. Product supplied frozen or lyophilized; compatible with various coagulation instruments and reagents per manufacturer instructions.
Clinical Evidence
Bench testing only. Performance verified by comparing assay results to known samples. Donors screened negative for HIV 1/2, HBsAG, HCV, and HIV-1ag. Factor deficiency confirmed at <1% with no inhibitors present.
Technological Characteristics
Human plasma immunodepleted of Factor V antigen; includes various buffers. Supplied frozen or lyophilized. Compatible with standard clinical coagulation instrumentation. No electronic or software components.
Indications for Use
Indicated for patients suspected of congenital or acquired Factor V deficiency. Used for quantitative determination of Factor V levels via clotting assay in clinical laboratories.
K970607 — UNIVERSAL REAGENT FACTOR VII DEFICIENT PLASMA · Universal Reagents, Inc. · Apr 25, 1997
K971223 — CRYO CHECK FACTOR V DEFICIENT PLASMA · Precision Biologicals, Inc. · Jul 22, 1997
K970593 — UNIVERSAL REAGENT FACTOR VIII DEFICIENT PLASMA · Universal Reagents, Inc. · Apr 25, 1997
K961929 — FACTOR DEFICIENT PLASMA · Universal Reagents, Inc. · Oct 10, 1996
K964459 — UNIVERSAL REAGENT FACTOR X DEFICIENT PLASMA · Universal Reagents, Inc. · Dec 18, 1996
Submission Summary (Full Text)
{0}
UNIVERSAL REAGENTS, INC.
2858 North Pennsylvania Street
Indianapolis, Indiana 46205
PHONE: (317) 926-0015
FAX: (317) 926-0014
DEC 18 1996
K964270
# Non-Confidential Summary of Safety and Effectiveness
October 17, 1996
page 1 of 2
Universal Reagents, Inc.
2858 N. Pennsylvania St.
Indianapolis, IN 46205
Tel - (317) 926-0006
Fax - (317) 926-0014
**Official contact:** Jorge Miller, Director, Coagulation Products
**Proprietary or Trade Name:** Factor deficient coagulation plasma - V
**Common/Usual Name:** Qualitative and Quantitative Factor Deficiency Test - V
**Classification Name:** Qualitative and Quantitative Factor Deficiency Test
**Intended device:** Factor deficient coagulation plasma - V
**Predicate devices:** Helena - K792507 - Factor V
**Device description:** Factor deficient plasma to be free of antigen of Factor V utilized in *in vitro* diagnostic use.
## Intended use:
Indicated use - Factor deficient plasma, Factor - V is a human plasma immunodepleted of the specific factor and intended for use in the quantitative determination of the specific factor levels in patients suspected of congenital or acquired deficiency of this specific coagulation protein and is performed by clotting assay.
**Environment of use:** Clinical laboratories
## Comparison to predicate devices:
| Attribute | Intended product | Helena |
| --- | --- | --- |
| Use | | |
| Indicated for use in determination of coagulation of plasma | Yes | Yes |
| In vitro diagnostic use | Yes | Yes |
| Used as a quantitative assay | Yes | Yes |
| Design | | |
| Factor V deficient plasmas offered | Yes | Yes |
page 3 of 32
{1}
page 4 of 32
# Non-Confidential Summary of Safety and Effectiveness (continued)
October 17, 1996
page 2 of 2
## Comparison to predicate devices: (continued)
| Attribute | Intended products | Helena |
| --- | --- | --- |
| Packaging either - Frozen or Dry / lyophilized | Yes | Yes |
| Can be used with different instruments and reagents per manufacturer instructions | Yes | Yes |
| Materials | | |
| Donor human plasma | Yes | Yes |
| Various buffers | Yes | Yes |
| Performance Testing | | |
| Compare assay to known sample | Yes | Yes |
| Negative by FDA approved test for HIV 1/2 and HBsAG | Yes | Yes |
| Negative by FDA approved test for HCV and HIV-1ag | Yes | not known |
| Donor criteria | | |
| Deficiency of relevant factor less than 1% | Yes | not known |
| Negative for HIV and HBsAG | Yes | Yes |
| Negative for HCV, HIV-1ag | Yes | not known |
| No inhibitor present | Yes | not known |
## Differences
The only difference is that the intended product is claimed to be negative for HCV and HIV-1ag by an FDA approved test.
Any other differences that do exist would not have a significant effect on the safety or effectiveness of the device.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.